Neoclease Joins the LabCentral AI BioHub in Partnership with C10

We’re excited to announce that Neoclease is part of the inaugural LabCentral AI BioHub, created in partnership with C10 Labs, to explore the cutting edge of AI and biotechnology.

The AI BioHub is a dynamic accelerator bringing together founders, mentors, and technical talent from across industries to tackle some of the most pressing challenges in life sciences. This program provides a unique opportunity to collaborate with a diverse cohort of innovators while leveraging world-class resources at LabCentral.

Over the coming weeks, we’ll participate in sessions focused on: 📍 Exploring the Role of AI in Driving Innovation and Venture Growth

📍 Building and Refining AI Experiments for Real-World Applications

📍 Leveraging Pre-Built Tools and Frameworks for Faster Development

📍 Gaining Insights on Navigating Commercialization Challenges

📍 Collaborating in a Two-Day Hackathon to Transform Ideas into Solutions

For Neoclease, this marks an important milestone as we continue advancing our mission to revolutionize gene editing. By applying AI-driven enzyme design and synthetic biology, we’re working to unlock new therapeutic possibilities for genetic disorders.

The LabCentral AI BioHub aligns perfectly with our vision, where AI innovation meets real-world impact in healthcare. We’re especially looking forward to collaborating with the other teams and mentors to accelerate breakthroughs in the field.

Stay tuned for updates as we share insights, progress, and highlights from this incredible journey.